StockData
Invivyd, Inc. logo

Invivyd, Inc. (IVVD) stock

IVVDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 9/3048% below fair value
$0.51−0.03 (-4.67%)

Close on Nov 17, 2026Market cap $151.09MP/E –Yield –

Invivyd cash

Cash and short-term investments held at the end of each period.

Invivyd's cash was $160.08M at Jun 30, 2026. For fiscal 2025 it was $226.69M, up 226.9% from the year before. The highest annual figure on record is $542.22M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$226.69M+226.9%
FY2024Dec 31, 2024$69.35M-65.4%
FY2023Dec 31, 2023$200.64M+117.9%
FY2022Dec 31, 2022$92.08M-83.0%
FY2021Dec 31, 2021$542.22M+371.5%
FY2020Dec 31, 2020$114.99M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$160.08M+358.6%
Q1 FY2026Mar 31, 2026$184.15M+283.0%
Q4 FY2025Dec 31, 2025$226.69M+226.9%
Q3 FY2025Sep 30, 2025$84.97M-20.5%
Q2 FY2025Jun 30, 2025$34.91M-76.4%
Q1 FY2025Mar 31, 2025$48.08M-74.6%
Q4 FY2024Dec 31, 2024$69.35M-65.4%
Q3 FY2024Sep 30, 2024$106.87M-41.2%
Q2 FY2024Jun 30, 2024$147.88M+21.3%
Q1 FY2024Mar 31, 2024$189.39M+49.7%
Q4 FY2023Dec 31, 2023$200.64M+117.9%
Q3 FY2023Sep 30, 2023$181.82M-34.6%
Q2 FY2023Jun 30, 2023$121.95M-74.3%
Q1 FY2023Mar 31, 2023$126.47M-76.2%
Q4 FY2022Dec 31, 2022$92.08M-83.0%
Q3 FY2022Sep 30, 2022$278.15M-41.8%
Q2 FY2022Jun 30, 2022$474.89M+21.0%
Q1 FY2022Mar 31, 2022$532.22M+483.3%
Q4 FY2021Dec 31, 2021$542.22M+371.5%
Q3 FY2021Sep 30, 2021$478.27M+884.6%
Q2 FY2021Jun 30, 2021$392.51M–
Q1 FY2021Mar 31, 2021$91.25M–
Q4 FY2020Dec 31, 2020$114.99M–
Q3 FY2020Sep 30, 2020$48.58M–

More Invivyd figures

See a number that looks wrong?